Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neurofibrosarcoma 3Neurofibromatosis 1 3Sarcoma 2Sarcoma, Kaposi 1Acquired Immunodeficiency Syndrome 1AIDS-related Kaposi sarcoma 1

Interventions

Doxorubicin 10Zidovudine 9Vincristine 7Bleomycin 7Nivolumab 6Liposomes 5Interferon alpha-2 5Etoposide 5tecogalan 4pembrolizumab 4liposomal doxorubicin 4Valganciclovir 4Specimen Handling 4Semaxinib 4Paclitaxel 4Nelfinavir 4Magnetic Resonance Spectroscopy 4pomalidomide 3Ritonavir 3Filgrastim 3Biopsy 3Bevacizumab 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2sargramostim 2interferon alfa-n1 2Propranolol 2Indinavir 2Docetaxel 2Didanosine 2Daunorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Kaposi × AZD 6244 × Sarcoma × Clear all
NCT01752569 2019-02-20

SCART

Sheffield Teaching Hospitals NHS Foundation Trust

Phase 1/2 Terminated
19 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡